Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 67,390 $ 129,758
Equity method investments 3,993,054 3,612,394
Receivables, net of allowance of $54 million and $50 million, respectively 2,961,388 2,895,837
Receivables held-for-sale 92,280 75,556
Real estate 2,981 2,984
Investments 7,006 6,818
Securitization assets, net of allowance of $3 million and $3 million, respectively 264,829 248,688
Other assets 87,033 108,210
Total Assets 7,475,961 7,080,245
Liabilities:    
Accounts payable, accrued expenses and other 282,591 275,639
Credit facilities 995 1,001
Commercial paper notes 430,417 100,057
Term loans payable 403,049 407,978
Senior unsecured notes 3,144,617 3,139,363
Convertible notes 618,335 619,543
Total Liabilities 5,005,217 4,675,170
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 120,708,587 and 118,960,353 shares issued and outstanding, respectively 1,207 1,190
Additional paid-in capital 2,646,415 2,592,964
Accumulated deficit (291,895) (297,499)
Accumulated other comprehensive income (loss) 37,675 40,101
Non-controlling interest 77,342 68,319
Total Stockholders’ Equity 2,470,744 2,405,075
Total Liabilities and Stockholders’ Equity 7,475,961 7,080,245
Non-recourse debt    
Liabilities:    
Non-recourse debt (secured by assets of $300 million and $307 million, respectively) $ 125,213 $ 131,589